These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 22388936)

  • 21. Bioinformatic perspectives in the neuronal ceroid lipofuscinoses.
    Kmoch S; Stránecký V; Emes RD; Mitchison HM
    Biochim Biophys Acta; 2013 Nov; 1832(11):1831-41. PubMed ID: 23274885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A CLN8 nonsense mutation in the whole genome sequence of a mixed breed dog with neuronal ceroid lipofuscinosis and Australian Shepherd ancestry.
    Guo J; Johnson GS; Brown HA; Provencher ML; da Costa RC; Mhlanga-Mutangadura T; Taylor JF; Schnabel RD; O'Brien DP; Katz ML
    Mol Genet Metab; 2014 Aug; 112(4):302-9. PubMed ID: 24953404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Common pathogenic effects of missense mutations in the P-type ATPase ATP13A2 (PARK9) associated with early-onset parkinsonism.
    Podhajska A; Musso A; Trancikova A; Stafa K; Moser R; Sonnay S; Glauser L; Moore DJ
    PLoS One; 2012; 7(6):e39942. PubMed ID: 22768177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic basis and phenotypic correlations of the neuronal ceroid lipofusinoses.
    Warrier V; Vieira M; Mole SE
    Biochim Biophys Acta; 2013 Nov; 1832(11):1827-30. PubMed ID: 23542453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The neuronal ceroid lipofuscinoses in human EPMR and mnd mutant mice are associated with mutations in CLN8.
    Ranta S; Zhang Y; Ross B; Lonka L; Takkunen E; Messer A; Sharp J; Wheeler R; Kusumi K; Mole S; Liu W; Soares MB; Bonaldo MF; Hirvasniemi A; de la Chapelle A; Gilliam TC; Lehesjoki AE
    Nat Genet; 1999 Oct; 23(2):233-6. PubMed ID: 10508524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel mutations in ATP13A2 associated with mixed neurological presentations and iron toxicity due to nonsense-mediated decay.
    Kırımtay K; Temizci B; Gültekin M; Yapıcı Z; Karabay A
    Brain Res; 2021 Jan; 1750():147167. PubMed ID: 33091395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kufor-Rakeb Syndrome/PARK9: One Novel and One Possible Recurring Ashkenazi ATP13A2 Mutation.
    Inzelberg R; Estrada-Cuzcano A; Laitman Y; De Vriendt E; Friedman E; Jordanova A
    J Parkinsons Dis; 2018; 8(3):399-403. PubMed ID: 29966207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A homozygous mutation in KCTD7 links neuronal ceroid lipofuscinosis to the ubiquitin-proteasome system.
    Staropoli JF; Karaa A; Lim ET; Kirby A; Elbalalesy N; Romansky SG; Leydiker KB; Coppel SH; Barone R; Xin W; MacDonald ME; Abdenur JE; Daly MJ; Sims KB; Cotman SL
    Am J Hum Genet; 2012 Jul; 91(1):202-8. PubMed ID: 22748208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel in-frame deletion in MFSD8 gene revealed by trio whole exome sequencing in an Iranian affected with neuronal ceroid lipofuscinosis type 7: a case report.
    Hosseini Bereshneh A; Garshasbi M
    J Med Case Rep; 2018 Sep; 12(1):281. PubMed ID: 30249282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations in DNAJC5, encoding cysteine-string protein alpha, cause autosomal-dominant adult-onset neuronal ceroid lipofuscinosis.
    Nosková L; Stránecký V; Hartmannová H; Přistoupilová A; Barešová V; Ivánek R; Hůlková H; Jahnová H; van der Zee J; Staropoli JF; Sims KB; Tyynelä J; Van Broeckhoven C; Nijssen PC; Mole SE; Elleder M; Kmoch S
    Am J Hum Genet; 2011 Aug; 89(2):241-52. PubMed ID: 21820099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging links between pediatric lysosomal storage diseases and adult parkinsonism.
    Ysselstein D; Shulman JM; Krainc D
    Mov Disord; 2019 May; 34(5):614-624. PubMed ID: 30726573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The novel neuronal ceroid lipofuscinosis gene MFSD8 encodes a putative lysosomal transporter.
    Siintola E; Topcu M; Aula N; Lohi H; Minassian BA; Paterson AD; Liu XQ; Wilson C; Lahtinen U; Anttonen AK; Lehesjoki AE
    Am J Hum Genet; 2007 Jul; 81(1):136-46. PubMed ID: 17564970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuronal ceroid lipofuscinosis associated with an MFSD8 mutation in Chihuahuas.
    Ashwini A; D'Angelo A; Yamato O; Giordano C; Cagnotti G; Harcourt-Brown T; Mhlanga-Mutangadura T; Guo J; Johnson GS; Katz ML
    Mol Genet Metab; 2016 Aug; 118(4):326-32. PubMed ID: 27211611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recessively inherited parkinsonism: effect of ATP13A2 mutations on the clinical and neuroimaging phenotype.
    Brüggemann N; Hagenah J; Reetz K; Schmidt A; Kasten M; Buchmann I; Eckerle S; Bähre M; Münchau A; Djarmati A; van der Vegt J; Siebner H; Binkofski F; Ramirez A; Behrens MI; Klein C
    Arch Neurol; 2010 Nov; 67(11):1357-63. PubMed ID: 21060012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ATP13A2 mutations impair mitochondrial function in fibroblasts from patients with Kufor-Rakeb syndrome.
    Grünewald A; Arns B; Seibler P; Rakovic A; Münchau A; Ramirez A; Sue CM; Klein C
    Neurobiol Aging; 2012 Aug; 33(8):1843.e1-7. PubMed ID: 22296644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A rare homozygous MFSD8 single-base-pair deletion and frameshift in the whole genome sequence of a Chinese Crested dog with neuronal ceroid lipofuscinosis.
    Guo J; O'Brien DP; Mhlanga-Mutangadura T; Olby NJ; Taylor JF; Schnabel RD; Katz ML; Johnson GS
    BMC Vet Res; 2015 Jan; 10():960. PubMed ID: 25551667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cln3-mutations underlying juvenile neuronal ceroid lipofuscinosis cause significantly reduced levels of Palmitoyl-protein thioesterases-1 (Ppt1)-protein and Ppt1-enzyme activity in the lysosome.
    Appu AP; Bagh MB; Sadhukhan T; Mondal A; Casey S; Mukherjee AB
    J Inherit Metab Dis; 2019 Sep; 42(5):944-954. PubMed ID: 31025705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinico-pathological manifestations of variant late infantile neuronal ceroid lipofuscinosis (vLINCL) caused by a novel mutation in MFSD8 gene.
    Mandel H; Cohen Katsanelson K; Khayat M; Chervinsky I; Vladovski E; Iancu TC; Indelman M; Horovitz Y; Sprecher E; Shalev SA; Spiegel R
    Eur J Med Genet; 2014; 57(11-12):607-12. PubMed ID: 25270050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exome sequencing identifies a novel homozygous CLN8 mutation in a Turkish family with Northern epilepsy.
    Sahin Y; Güngör O; Gormez Z; Demirci H; Ergüner B; Güngör G; Dilber C
    Acta Neurol Belg; 2017 Mar; 117(1):159-167. PubMed ID: 27844444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations.
    Paisán-Ruiz C; Guevara R; Federoff M; Hanagasi H; Sina F; Elahi E; Schneider SA; Schwingenschuh P; Bajaj N; Emre M; Singleton AB; Hardy J; Bhatia KP; Brandner S; Lees AJ; Houlden H
    Mov Disord; 2010 Sep; 25(12):1791-800. PubMed ID: 20669327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.